You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Background characteristics of the study participants at commencement of HAART, total and sex segregated

From: Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda

Characteristic Total (N = 1741) Female (N = 1413) Male (N = 328) p-value*
Age in years, median (IQR) 44(37,50) 43(37,49) 45(40,52) 0.001
WHO stage III & IV, n (%) 1113(63.9) 929(65.7) 184(56.1) 0.121
CD4 cells/μl, median (IQR) (2005–6) 128(55,190) 144(65,191) 49(39,92) 0.074
ART regime (2005–2013), n (%)     
  d4T + 3TC+ NVP 693(40) 638(45) 136(41) 0.233
  ZDV +3TC + NPV 774(44) 562(40) 131(40)
  other 274(16) 213(15) 61(19)
  1. Key: *Chi2-Test; IQR = Interquartile range; ART = Antiretroviral therapy; d4T = Stavudine; 3TC = Lamivudine, NVP = Nevirapine; ZDV = Zidovudine, WHO = World Health Organisation.